Eurocine Vaccines has Completed Dosing of its Quadrivalent Influenza Vaccine Candidate, Immunose™ FLU, in the Second Clinical Study

STOCKHOLM, May 18. 2018 /PRNewswire/ — This week, dosing was completed according to plan in the second clinical study with Immunose™ FLU, developed with the aim to become a modern and effective nasal influenza vaccine.
– In the perspective of this year’s severe influenza outburst we…